Movano Health (Nasdaq:MOVE) announced today that it commenced a blood pressure clinical trial with its new cuffless wrist wearable.

Movano (MOVE) has commenced a blood pressure clinical trial with its newly developed cuffless blood pressure wrist wearable. The study, which ...

"I'm excited about the potential the enhanced design offers relative to our previous prototype as it represents a significant leap forward in cuffless blood pressure monitoring." Founded in 2018 ...

During each session, participants wore Movano Health's wrist-worn device along with a hospital-grade FDA-cleared vital signs monitor with cuffed blood pressure measurements or utilizing arterial ...

utilizes the updated device to monitor pulse pressure waveforms in comparison with a hospital grade blood pressure device. The new wearable will also collect data on a host of other vital signs ...

Medtech companies have their eye on the growing hospital-at-home market, which is driven largely by the rising elderly ...

Additionally, the systolic number may be slightly off in comparison to a professional-grade monitor. Overall, we believe the iHealth Track Smart Upper Arm Blood Pressure Monitor is a great ...

CBD has shown promise as a treatment for psychosis in small studies and case reports. A large, international trial launching ...

Dr Besigye and Mr Lutale were on November 16, 2025 abducted from Nairobi. They resurfaced on November 20 when they were ...